# Yun Ling

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yun-ling/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,971 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 62 |
| i10-index | 214 |
| Last Known Institution | Zhejiang Chinese Medical University |
| OpenAlex ID | https://openalex.org/A5045085415 |
| ORCID iD | https://orcid.org/0000-0002-4289-3594 |
| Works | 461 |

## Researcher papers

- [COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas](https://scholariq.org/papers/covid-19-immune-features-revealed-by-a-large-scale-single-cell-transcriptome/)
- [COVID-19 with Different Severities: A Multicenter Study of Clinical Features](https://scholariq.org/papers/covid-19-with-different-severities-a-multicenter-study-of-clinical-features/)
- [Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC](https://scholariq.org/papers/neoadjuvant-pd-1-inhibitor-sintilimab-in-nsclc/)
- [Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma](https://scholariq.org/papers/open-label-multicenter-phase-ii-study-of-rc48-adc-a-her2-targeting-antibody-drug/)
- [Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells](https://scholariq.org/papers/endostar-a-novel-recombinant-human-endostatin-exerts-antiangiogenic-effect-via/)
- [Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells](https://scholariq.org/papers/flavonoid-baicalein-suppresses-adhesion-migration-and-invasion-of-mda-mb-231/)
- [COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas](https://scholariq.org/papers/covid-19-immune-features-revealed-by-a-large-scale-single-cell-transcriptome-2/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Zhejiang Chinese Medical University](https://scholariq.org/institutions/zhejiang-chinese-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.